Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 13.10% and Operating profit at 16.19% over the last 5 years
2
Flat results in Mar 26
3
With ROE of 8.66%, it has a very attractive valuation with a 0.48 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.83%
0%
14.83%
6 Months
8.27%
0%
8.27%
1 Year
29.27%
0%
29.27%
2 Years
2.42%
0%
2.42%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Zhejiang Haisen Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.10%
EBIT Growth (5y)
16.19%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.34
Tax Ratio
13.11%
Dividend Payout Ratio
12.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.73%
ROE (avg)
8.77%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.83
EV to EBIT
12.12
EV to EBITDA
10.70
EV to Capital Employed
3.77
EV to Sales
3.32
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
31.09%
ROE (Latest)
8.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
143.70
123.60
16.26%
Operating Profit (PBDIT) excl Other Income
47.90
37.40
28.07%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
36.80
29.60
24.32%
Operating Profit Margin (Excl OI)
285.20%
262.40%
2.28%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 16.26% vs 30.38% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 24.32% vs 19.84% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
529.70
468.30
13.11%
Operating Profit (PBDIT) excl Other Income
166.30
133.70
24.38%
Interest
0.60
0.60
Exceptional Items
1.80
0.00
Consolidate Net Profit
135.90
122.60
10.85%
Operating Profit Margin (Excl OI)
269.20%
249.20%
2.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024
About Zhejiang Haisen Pharmaceutical Co., Ltd. 
Zhejiang Haisen Pharmaceutical Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






